BACKGROUND: The "Dutch hypothesis" suggests that asthma and COPD have common genetic determinants. The serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2) gene previously has been associated with COPD. We sought to determine whether SERPINE2 is associated with asthma and asthma-related phenotypes. METHODS: We measured the association of 39 SERPINE2 single-nucleotide polymorphisms (SNPs) with asthma-related phenotypes in 655 parent-child trios from the Childhood Asthma Management Program (CAMP), and we measured the association of 19 SERPINE2 SNPs with asthma in a case-control design of 359 CAMP probands and 846 population control subjects. We attempted to replicate primary asthma-related phenotype findings in one independent population and primary asthma affection status findings in two independent populations. We compared association results with CAMP proband expression quantitative trait loci. RESULTS: Nine of 39 SNPs had P < .05 for at least one phenotype in CAMP, and two of these replicated in an independent population of 426 people with childhood asthma. Six of 19 SNPs had P < .05 for association with asthma in CAMP/Illumina. None of these replicated in two independent populations. The expression quantitative trait loci revealed that five SNPs associated with asthma in CAMP/Illumina and one SNP associated with FEV(1) in CAMP are strongly correlated with SERPINE2 expression levels. Comparison of results to previous COPD studies identified five SNPs associated with both asthma- and COPD-related phenotypes. CONCLUSIONS: Our results weakly support SERPINE2 as a Dutch hypothesis candidate gene through nominally significant associations with asthma and related traits. Further study of SERPINE2 is necessary to verify its involvement in asthma and COPD.
BACKGROUND: The "Dutch hypothesis" suggests that asthma and COPD have common genetic determinants. The serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2) gene previously has been associated with COPD. We sought to determine whether SERPINE2 is associated with asthma and asthma-related phenotypes. METHODS: We measured the association of 39 SERPINE2 single-nucleotide polymorphisms (SNPs) with asthma-related phenotypes in 655 parent-child trios from the Childhood Asthma Management Program (CAMP), and we measured the association of 19 SERPINE2 SNPs with asthma in a case-control design of 359 CAMP probands and 846 population control subjects. We attempted to replicate primary asthma-related phenotype findings in one independent population and primary asthma affection status findings in two independent populations. We compared association results with CAMP proband expression quantitative trait loci. RESULTS: Nine of 39 SNPs had P < .05 for at least one phenotype in CAMP, and two of these replicated in an independent population of 426 people with childhood asthma. Six of 19 SNPs had P < .05 for association with asthma in CAMP/Illumina. None of these replicated in two independent populations. The expression quantitative trait loci revealed that five SNPs associated with asthma in CAMP/Illumina and one SNP associated with FEV(1) in CAMP are strongly correlated with SERPINE2 expression levels. Comparison of results to previous COPD studies identified five SNPs associated with both asthma- and COPD-related phenotypes. CONCLUSIONS: Our results weakly support SERPINE2 as a Dutch hypothesis candidate gene through nominally significant associations with asthma and related traits. Further study of SERPINE2 is necessary to verify its involvement in asthma and COPD.
Authors: Dirkje S Postma; Deborah A Meyers; Hajo Jongepier; Timothy D Howard; Gerard H Koppelman; Eugene R Bleecker Journal: Am J Respir Crit Care Med Date: 2005-05-18 Impact factor: 21.405
Authors: Alka Malhotra; Andy P Peiffer; Darin T Ryujin; Tami Elsner; Richard E Kanner; Mark F Leppert; Sandra J Hasstedt Journal: Am J Respir Crit Care Med Date: 2003-06-05 Impact factor: 21.405
Authors: Dawn L Demeo; Thomas J Mariani; Christoph Lange; Sorachai Srisuma; Augusto A Litonjua; Juan C Celedon; Stephen L Lake; John J Reilly; Harold A Chapman; Brigham H Mecham; Kathleen J Haley; Jody S Sylvia; David Sparrow; Avrum E Spira; Jennifer Beane; Victor Pinto-Plata; Frank E Speizer; Steven D Shapiro; Scott T Weiss; Edwin K Silverman Journal: Am J Hum Genet Date: 2005-12-15 Impact factor: 11.025
Authors: Dawn L DeMeo; Juan C Celedón; Christoph Lange; John J Reilly; Harold A Chapman; Jody S Sylvia; Frank E Speizer; Scott T Weiss; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2004-09-03 Impact factor: 21.405
Authors: R E Carter; K M Cerosaletti; D J Burkin; R E Fournier; C Jones; B D Greenberg; B A Citron; B W Festoff Journal: Genomics Date: 1995-05-01 Impact factor: 5.736
Authors: Joanna Smolonska; Gerard H Koppelman; Cisca Wijmenga; Judith M Vonk; Pieter Zanen; Marcel Bruinenberg; Ivan Curjuric; Medea Imboden; Gian-Andri Thun; Lude Franke; Nicole M Probst-Hensch; Peter Nürnberg; Roland A Riemersma; Constant P van Schayck; Daan W Loth; Guy G Brusselle; Bruno H Stricker; Albert Hofman; André G Uitterlinden; Lies Lahousse; Stephanie J London; Laura R Loehr; Ani Manichaikul; R Graham Barr; Kathleen M Donohue; Stephen S Rich; Peter Pare; Yohan Bossé; Ke Hao; Maarten van den Berge; Harry J M Groen; Jan-Willem J Lammers; Willem Mali; H Marike Boezen; Dirkje S Postma Journal: Eur Respir J Date: 2014-07-03 Impact factor: 16.671
Authors: Simone Accordini; Lucia Calciano; Cristina Bombieri; Giovanni Malerba; Francesca Belpinati; Anna Rita Lo Presti; Alessandro Baldan; Marcello Ferrari; Luigi Perbellini; Roberto de Marco Journal: PLoS One Date: 2016-03-17 Impact factor: 3.240
Authors: Jarrett D Morrow; Xiaobo Zhou; Taotao Lao; Zhiqiang Jiang; Dawn L DeMeo; Michael H Cho; Weiliang Qiu; Suzanne Cloonan; Victor Pinto-Plata; Bartholome Celli; Nathaniel Marchetti; Gerard J Criner; Raphael Bueno; George R Washko; Kimberly Glass; John Quackenbush; Augustine M K Choi; Edwin K Silverman; Craig P Hersh Journal: Sci Rep Date: 2017-03-13 Impact factor: 4.379
Authors: Aniruddha Rathod; Hongmei Zhang; Syed Hasan Arshad; Susan Ewart; Caroline L Relton; Wilfried Karmaus; John W Holloway Journal: J Pers Med Date: 2022-02-02
Authors: Cosetta Minelli; Charlotte H Dean; Matthew Hind; Alexessander Couto Alves; André F S Amaral; Valerie Siroux; Ville Huikari; María Soler Artigas; David M Evans; Daan W Loth; Yohan Bossé; Dirkje S Postma; Don Sin; John Thompson; Florence Demenais; John Henderson; Emmanuelle Bouzigon; Deborah Jarvis; Marjo-Riitta Järvelin; Peter Burney Journal: PLoS One Date: 2016-02-02 Impact factor: 3.240
Authors: Andréanne Morin; Anne-Marie Madore; Tony Kwan; Maria Ban; Jukka Partanen; Lars Rönnblom; Ann-Christine Syvänen; Stephen Sawcer; Hendrik Stunnenberg; Mark Lathrop; Tomi Pastinen; Catherine Laprise Journal: Eur J Hum Genet Date: 2018-09-11 Impact factor: 4.246